BMN 110 Phase 3B in Australian Patients

Clinical trial NCT01966029 · COMPLETED

Trial details

NCT number: NCT01966029
Sponsor: BioMarin Pharmaceutical
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mucopolysaccharidosis IVA (Morquio A Syndrome)

Start date: 2013-07-01
Primary completion: 2016-07-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.